The transcription factor FOXP2 carries two amino acid substitutions (T303N and N325S) that arose on the human lineage since divergence from chimpanzees. When introduced into the endogenous mouse Foxp2 gene, these substitutions increase dendrite length and long-term depression (LTD) of striatal medium spiny neurons, reduce striatal tissue dopamine, and alter pup ultrasonic vocalizations. More than fifteen years of follow-up work has narrowed where these effects occur and which substitution drives the plasticity phenotype, but the causal chain from the two substitutions to the circuit phenotype remains open: which striatal gene-expression changes are direct in-vivo targets of the humanized protein (in which cell types and at which developmental stages), how reduced tissue dopamine relates to extracellular dopaminergic signaling and arises without Foxp2 expression in midbrain dopaminergic neurons, and whether the vocalization changes are central rather than peripheral in origin.

Background

FOXP2 (forkhead box P2) is a transcription factor — a protein that regulates the expression of other genes by binding DNA — and remains the only gene firmly linked to human speech and language development: heterozygous loss-of-function mutations cause a severe developmental disorder affecting the learning and sequencing of orofacial movements needed for speech. Enard et al. (2002) reported that two amino acid substitutions in FOXP2, T303N and N325S, became fixed on the human lineage after its divergence from the chimpanzee lineage and proposed that they were positively selected in connection with speech evolution (a premise later weakened by population-genomic reanalysis: Atkinson et al. 2018 found no evidence of recent selection at FOXP2 across modern human populations). To test functional consequences, Enard et al. (2009) introduced both substitutions into the endogenous mouse Foxp2 gene, producing Foxp2hum/humFoxp2^{hum/hum} ("humanized") mice. These mice are healthy but show decreased exploratory behavior, qualitatively altered pup isolation calls (ultrasonic vocalizations, USVs — the high-frequency sounds rodent pups emit when isolated), reduced tissue concentrations of dopamine in all five brain regions examined, and, in the striatum — the input structure of the basal ganglia, which integrates cortical glutamatergic and midbrain dopaminergic input and is structurally and functionally abnormal in humans carrying one nonfunctional FOXP2 allele — medium spiny neurons (the principal striatal neurons, making up over 90% of striatal cells) with increased dendrite length and increased long-term depression (LTD, an activity-dependent weakening of synaptic transmission) at corticostriatal synapses. Strikingly, mice carrying one nonfunctional Foxp2 allele show the opposite effects on each of these traits.

Follow-up work refined this picture without resolving mechanism. Reimers-Kipping et al. (2011) showed the dendrite and LTD effects occur in brain regions interconnected by cortico-basal ganglia circuits (cortex, thalamus, striatum) but not in amygdala or cerebellum. Schreiweis et al. (2014) found that dopamine levels are reduced to about 70% of wild-type selectively in the dorsomedial striatum (leaving dorsolateral striatum unchanged), that the excess LTD there depends on NMDA receptors (a subtype of ionotropic glutamate receptor) and is modulated by D2 dopamine receptors, and that Foxp2hum/humFoxp2^{hum/hum} mice learn stimulus-response associations faster when declarative (place-based) and procedural (response-based) strategies compete. Schreiweis et al. (2019) showed the humanized allele itself shifts Foxp2 protein expression levels across striatal regions and compartments. Bornschein et al. (2023) generated mice carrying each substitution separately and found that T303N alone fully recapitulates the increased LTD, while N325S has no discernible effect. On the vocalization thread, Hammerschmidt et al. (2015) found no effect on adult male courtship USVs, but von Merten et al. (2021), using a paradigm with extended social contact in both sexes, found higher frequencies and more complex syllables in humanized mice, so the adult phenotype is paradigm-dependent and the significance of pup-call changes remains contested.

In parallel, the molecular target landscape of FOXP2 was mapped outside the humanized-mouse context: Vernes et al. (2007) and Spiteri et al. (2007) identified direct FOXP2-bound promoters in human neuronal cell lines and developing human fetal brain; Nelson et al. (2013) showed human and chimpanzee FOXP2 have essentially the same DNA-binding specificity (while identifying 38 evolutionarily novel human binding sites); and Chen et al. (2016) demonstrated that mouse Foxp2 directly represses the synapse-suppressor gene Mef2c, thereby controlling corticostriatal synapse formation and neonatal vocalization. Co et al. (2020) linked cortical Foxp2 to developmental expression of the D1 dopamine receptor. Reviews by den Hoed et al. (2021) and Valle-Bautista et al. (2024) synthesize this literature and state that FOXP2's in-vivo regulatory capabilities and downstream molecular pathways remain largely unknown — for example, its interactions with chromatin-remodeling cofactors such as the NuRD complex (nucleosome remodeling and deacetylase, a co-repressor complex that FOXP2 recruits to repress target genes) have been characterized mainly in cell lines, not in the developing brain.

Problem Statement

Determine the mechanism by which the two human-specific amino acid substitutions in FOXP2 (T303N and N325S, of which T303N alone suffices for the increased striatal long-term depression) produce the observed alterations of cortico-basal ganglia circuits in Foxp2hum/humFoxp2^{hum/hum} knock-in mice. The mechanism remains open along three interrelated lines of inquiry: (1) which genotype-dependent gene-expression changes in the striatum are direct in-vivo regulatory targets of the humanized FOXP2 protein — in which striatal cell types and at which developmental time points — and by what molecular route (DNA binding, cofactor or chromatin-remodeling-complex recruitment such as the NuRD complex, dimerization) the substitutions alter transcriptional output; (2) how the reduced striatal tissue dopamine relates to extracellular dopaminergic signaling in vivo, i.e., whether release, reuptake, or storage pools are altered, and what upstream mechanism produces this change, given that Foxp2 is not expressed in midbrain dopaminergic neurons; and (3) whether the altered pup isolation calls, and the paradigm-dependent adult ultrasonic vocalization differences, reflect changes in neural circuits homologous to those underlying learned vocal control rather than peripheral effects such as subtle lung or laryngeal differences. Together these lines of inquiry define one objective: a mechanistic explanation of the humanized-Foxp2 circuit phenotype from transcriptional regulation to circuit properties. These three lines are jointly required parts of that single objective: a complete resolution must address all three, so progress on any one line alone is a partial contribution rather than a resolution. The source also raises the interpretive question of whether such cortico-basal ganglia alterations plausibly map onto phenotypic differences between humans and apes; this comparative dimension is open-ended, forms part of the context in which the mechanistic objective is pursued, and is not required to resolve the task.

References

  1. Enard W, Gehre S, Hammerschmidt K, Hölter SM, Blass T, Somel M, Brückner MK, Schreiweis C, Winter C, Sohr R, Becker L, Wiebe V, Nickel B, Giger T, Müller U, Groszer M, Adler T, Aguilar A, Bolle I, Calzada-Wack J, Dalke C, Ehrhardt N, Favor J, Fuchs H, Gailus-Durner V, Hans W, Hölzlwimmer G, Javaheri A, Kalaydjiev S, Kallnik M, Kling E, Kunder S, Moßbrugger I, Naton B, Racz I, Rathkolb B, Rozman J, Schrewe A, Busch DH, Graw J, Ivandic B, Klingenspor M, Klopstock T, Ollert M, Quintanilla-Martinez L, Schulz H, Wolf E, Wurst W, Zimmer A, Fisher SE, Morgenstern R, Arendt T, Hrabé de Angelis M, Fischer J, Schwarz J, Pääbo S (2009). A Humanized Version of Foxp2 Affects Cortico-Basal Ganglia Circuits in Mice. Cell 137(5):961–971. doi:10.1016/j.cell.2009.03.041, https://doi.org/10.1016/j.cell.2009.03.041
  2. Enard W, Przeworski M, Fisher SE, Lai CSL, Wiebe V, Kitano T, Monaco AP, Pääbo S (2002). Molecular evolution of FOXP2, a gene involved in speech and language. Nature 418(6900):869–872. doi:10.1038/nature01025, https://doi.org/10.1038/nature01025
  3. Reimers-Kipping S, Hevers W, Pääbo S, Enard W (2011). Humanized Foxp2 specifically affects cortico-basal ganglia circuits. Neuroscience 175:75–84. doi:10.1016/j.neuroscience.2010.11.042, https://doi.org/10.1016/j.neuroscience.2010.11.042
  4. Schreiweis C, Bornschein U, Burguière E, Kerimoglu C, Schreiter S, Dannemann M, Goyal S, Rea E, French CA, Puliyadi R, Groszer M, Fisher SE, Mundry R, Winter C, Hevers W, Pääbo S, Enard W, Graybiel AM (2014). Humanized Foxp2 accelerates learning by enhancing transitions from declarative to procedural performance. Proceedings of the National Academy of Sciences USA 111(39):14253–14258. doi:10.1073/pnas.1414542111, https://doi.org/10.1073/pnas.1414542111
  5. Hammerschmidt K, Schreiweis C, Minge C, Pääbo S, Fischer J, Enard W (2015). A humanized version of Foxp2 does not affect ultrasonic vocalization in adult mice. Genes, Brain and Behavior 14(8):583–590. doi:10.1111/gbb.12237, https://doi.org/10.1111/gbb.12237
  6. von Merten S, Pfeifle C, Künzel S, Hoier S, Tautz D (2021). A humanized version of Foxp2 affects ultrasonic vocalization in adult female and male mice. Genes, Brain and Behavior 20(7):e12764. doi:10.1111/gbb.12764, https://doi.org/10.1111/gbb.12764
  7. Chen YC, Kuo HY, Bornschein U, Takahashi H, Chen SY, Lu KM, Yang HY, Chen GM, Lin JR, Lee YH, Chou YC, Cheng SJ, Chien CT, Enard W, Hevers W, Pääbo S, Graybiel AM, Liu FC (2016). Foxp2 controls synaptic wiring of corticostriatal circuits and vocal communication by opposing Mef2c. Nature Neuroscience 19(11):1513–1522. doi:10.1038/nn.4380, https://doi.org/10.1038/nn.4380
  8. Schreiweis C, Irinopoulou T, Vieth B, Laddada L, Oury F, Burguière E, Enard W, Groszer M (2019). Mice carrying a humanized Foxp2 knock-in allele show region-specific shifts of striatal Foxp2 expression levels. Cortex 118:212–222. doi:10.1016/j.cortex.2019.01.008, https://doi.org/10.1016/j.cortex.2019.01.008
  9. Co M, Hickey SL, Kulkarni A, Harper M, Konopka G (2020). Cortical Foxp2 supports behavioral flexibility and developmental dopamine D1 receptor expression. Cerebral Cortex 30(3):1855–1870. doi:10.1093/cercor/bhz209, https://doi.org/10.1093/cercor/bhz209
  10. den Hoed J, Devaraju K, Fisher SE (2021). Molecular networks of the FOXP2 transcription factor in the brain. EMBO Reports 22(8):e52803. doi:10.15252/embr.202152803, https://doi.org/10.15252/embr.202152803
  11. Bornschein U, Zeberg H, Enard W, Hevers W, Pääbo S (2023). Functional dissection of two amino acid substitutions unique to the human FOXP2 protein. Scientific Reports 13:3747. doi:10.1038/s41598-023-30663-3, https://doi.org/10.1038/s41598-023-30663-3
  12. Raghanti MA, Edler MK, Stephenson AR, Wilson LJ, Hopkins WD, Ely JJ, Erwin JM, Jacobs B, Hof PR, Sherwood CC (2016). Human-specific increase of dopaminergic innervation in a striatal region associated with speech and language: a comparative analysis of the primate basal ganglia. Journal of Comparative Neurology 524(10):2117–2129. doi:10.1002/cne.23937, https://doi.org/10.1002/cne.23937
  13. Nelson CS, Fuller CK, Fordyce PM, Greninger AL, Li H, DeRisi JL (2013). Microfluidic affinity and ChIP-seq analyses converge on a conserved FOXP2-binding motif in chimp and human, which enables the detection of evolutionarily novel targets. Nucleic Acids Research 41(12):5991–6004. doi:10.1093/nar/gkt259, https://doi.org/10.1093/nar/gkt259
  14. Vernes SC, Spiteri E, Nicod J, Groszer M, Taylor JM, Davies KE, Geschwind DH, Fisher SE (2007). High-throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and language disorders. American Journal of Human Genetics 81(6):1232–1250. doi:10.1086/522238, https://doi.org/10.1086/522238
  15. Spiteri E, Konopka G, Coppola G, Bomar J, Oldham M, Ou J, Vernes SC, Fisher SE, Ren B, Geschwind DH (2007). Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain. American Journal of Human Genetics 81(6):1144–1157. doi:10.1086/522237, https://doi.org/10.1086/522237
  16. Atkinson EG, Audesse AJ, Palacios JA, Bobo DM, Webb AE, Ramachandran S, Henn BM (2018). No evidence for recent selection at FOXP2 among diverse human populations. Cell 174(6):1424–1435.e15. doi:10.1016/j.cell.2018.06.048, https://doi.org/10.1016/j.cell.2018.06.048
  17. Valle-Bautista R, Olivera-Acevedo M, Horta-Brussolo VR, Díaz NF, Ávila-González D, Molina-Hernández A (2024). From songbird to humans: the multifaceted roles of FOXP2 in speech and motor learning. Neuroscience & Biobehavioral Reviews 167:105936. doi:10.1016/j.neubiorev.2024.105936, https://doi.org/10.1016/j.neubiorev.2024.105936